Klick Health has announced the Grand Prize winner of the $1,000,000 Klick Prize, following the submission of several hundred AI ideas from employees for life sciences clients. The company shared key insights from its year-long internal contest and discussed the broader implications these findings have for the industry.
Klick Health has announced the Grand Prize winner of the $1,000,000 Klick Prize, following a year-long internal contest that generated several hundred employee-submitted AI ideas aimed at addressing real problems for life sciences clients. The contest showcased key trends and innovative applications of AI, which will play a transformative role in the industry in the coming years.
“The Klick Prize is about solving real problems and delivering measurable results,” said Leerom Segal, Klick Co-Founder and Chairman. “AI is a tool for transformation that can reshape what’s possible for our clients as we set the pace for life sciences innovation in 2025 and beyond.”
The Grand Prize-winning concept, Guardrail, is an AI-enhanced pharmaceutical marketing compliance tool that goes beyond simple predictive suggestions. It utilizes complex reasoning and a decision engine to ensure compliance, helping teams navigate regulatory frameworks more efficiently. Klick Health has already started using Guardrail internally to improve asset authoring, review, and Medical Legal and Regulatory (MLR) processes, with pilots underway with multiple clients.
Additionally, an AI/human interaction platform that simulates healthcare interactions and delivers industry insights also won in a round of the competition. This platform uses AI “agents” to act as patients and healthcare professionals, offering a richer market research experience and enhanced user simulations beyond basic chatbot interactions. The contest also highlighted how AI models are evolving beyond text-based chat interfaces to include voice-based interactions and multimedia production, encompassing text, images, and code.
As these trends evolve, Segal predicts that more AI solutions will become autonomous, driving meaningful engagement and improving commercialization efforts in life sciences. These advancements are expected to lead to more effective and personalized interactions between healthcare professionals, patients, and life sciences companies.
The Guardrail concept was developed by members of Klick’s Mediverse team alongside a tech developer and project manager. They will share the prize, in addition to their earlier winnings from the first round of the contest.
Other notable winning ideas include a personalized AI training tool for pharma sales reps using synthetic personas to simulate healthcare professionals, an AI-powered approach to creating branded messaging, a patient experience panel using a gaming engine to identify new in-market solutions, and an AI tool to help pharma companies modernize their standard operating procedures and regulatory compliance.
Entries were reviewed by a panel of senior executives from leading pharma companies such as BeiGene, Boehringer Ingelheim, and Pfizer. The ideas were evaluated on impact, feasibility, market differentiation, and desirability.
Beyond generating groundbreaking AI ideas, the Klick Prize also aimed to familiarize Klick Health employees with AI tools. “We encouraged our people to experiment with generative AI, providing them access to tools and AI coaches, allowing them to see their ideas turned into solutions that can make a difference,” Segal explained.
Klick Health’s continued investment in AI is evident in several other innovative projects. Earlier this year, Klick Labs introduced AI-driven research to detect chronic high blood pressure through vocal biomarkers. It also launched KCM+AI™, the first AI social media comment moderator for life sciences, and LOVENet™, an AI framework for discovering new uses for existing drugs. These innovations underscore Klick’s commitment to advancing the use of AI and machine learning to support healthcare clients and enhance outcomes across the life sciences industry.
Klick Health is the world’s largest independent commercialization partner for life sciences, specializing in marketing, media strategy, medical affairs, and omnichannel enablement. The company’s innovative work has earned it numerous accolades, including being named the 2024 Clio Health Independent Agency of the Year.
